NDC11 59651084960
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59651-0849-60 | 59651-0849 |
| 59651-849-60 | 59651-849 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivaroxaban | RIVAROXABAN | Aurobindo Pharma Limited | bcb0e6e7-3006-4d82-8009-c5fddbbfc80d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 59651-849-60 59651-849 59651084960 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.